v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 26,786 $ 14,933
Marketable securities 154,195 167,803
Accounts receivable, net of allowances and reserves of $3,653 and $4,040 as of March 31, 2025 and December 31, 2024, respectively 25,336 28,616
Deferred contract acquisition costs, current 9,951 10,784
Prepaid expenses and other current assets 8,343 6,194
Total current assets 224,611 228,330
Property and equipment, net 5,725 6,673
Operating right-of-use assets 1,938 2,297
Intangible asset, net 570 660
Deferred contract acquisition costs, non-current 11,985 12,199
Other long-term assets 949 794
Total assets 245,778 250,953
Current liabilities    
Accounts payable 1,924 2,746
Accrued and other current liabilities 13,541 16,394
Deferred revenue 71,559 66,687
Operating lease liabilities, current 1,687 2,372
Total current liabilities 88,711 88,199
Operating lease liabilities, non-current 1,014 1,016
Other long-term liabilities 2,327 2,326
Total liabilities 92,052 91,541
Commitments and contingencies (Note 8)
Stockholders’ equity    
Common stock, $0.0001 par value per share; 500,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 42,412,254 and 42,013,694 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 3 4
Additional paid-in capital 510,072 507,188
Accumulated deficit (356,372) (347,669)
Accumulated other comprehensive income (loss) 23 (111)
Total stockholders’ equity 153,726 159,412
Total liabilities and stockholders’ equity $ 245,778 $ 250,953